Neumora Therapeutics commits to accelerating Alzheimer agitation therapies

Neumora Therapeutics commits to accelerating Alzheimer agitation therapies
Neumora backs Alzheimer movement

Neumora Therapeutics is amplifying its involvement in Alzheimer awareness initiatives, partnering with the Alzheimer Association to support the EndAlz movement.

The company emphasized the rising burden of agitation in Alzheimer disease and reaffirmed its commitment to both raising awareness and advancing the development of innovative treatment solutions. This aligns with broader industry efforts to address critical unmet needs in neurodegenerative disease therapy. Details about the specific programs or drug candidates were not disclosed in the announcement.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.